| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.004 |